Jonathan Zuniga, MD
Nephrology · Hurricane, WVNPI 1831167212
Payments from drug & device makers
What this record shows
This record is dominated by education: $146 of the $177 with a category attached, or 82.4%. OPKO Pharmaceuticals, LLC accounts for 65.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $110 and has fallen 88.2% since, to $13 in 2025. That places this record below the midpoint for nephrology clinicians in WV, where the typical reported total is $740.
Across 13 payments — averaging $13.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- OPKO Pharmaceuticals, LLC$116
- Travere Therapeutics, Inc.$30
- Otsuka America Pharmaceutical, Inc.$18
- Ardelyx, Inc.$14
What the payments were for
- Food & beverage$3118%
- Education$14682%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| OPKO Pharmaceuticals, LLC | 6 | $116 |
| Travere Therapeutics, Inc. | 5 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $14 |
How this compares
$177 in reported general payments places this provider in the 30th percentile of 55 nephrology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 49 | $160,868 |
| Calcitriol | 704 | $11,469 |
| Sevelamer Carbonate | 66 | $9,256 |
| Torsemide | 224 | $3,222 |
| Furosemide | 390 | $2,172 |
| Potassium Chloride | 139 | $2,000 |
| Chlorthalidone | 249 | $1,911 |
| Midodrine Hcl | 23 | $1,817 |
| Hydralazine Hcl | 129 | $1,225 |
| Ramipril | 163 | $1,030 |
| Hydrochlorothiazide | 106 | $489 |
| Valsartan | 13 | $453 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 12 | $237 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $218 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 25 | $207 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Hurricane
- Julian EspirituSouth Charleston$215K
- Abdul ZanabliS Charleston$31K
- Murad KheetanHuntington$25K
- Arijit ChakravartyMorgantown$19K
- Asif RahmanCharleston$8K
- Mirza HamiraniVienna$8K
- Michael CollinsHuntington$7K
- Khan ShabihCharleston$6K
- Faroug SulimanCharleston$6K
- Ahmad EterBeckley$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.